Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2007

01-03-2007 | Case Report

Hepatocellular Carcinoma (HCC) with Portal Vein Invasion, Masquerading as Pancreatic Mass, Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA)

Authors: Ian Storch, Carmen Gomez, Francisco Contreras, Eugene Schiff, Afonso Ribeiro

Published in: Digestive Diseases and Sciences | Issue 3/2007

Login to get access

Excerpt

Hepatocellular carcinoma (HCC) is a common cause of death among patients with cirrhosis, with epidemiologic data suggesting that the mortality rate in the United States is on the rise [1]. Although screening for HCC ultrasound and AFP every 6 months in patients with cirrhosis is recommended for early detection, small lesions are often missed. Portal vein thrombosis secondary to HCC invasion often results in clinical decompensation and is a contraindication to resection or liver transplantation [2]. As portal vein thrombosis secondary to clot is common among patients with cirrhosis, determination of a clear etiology is important in these patients. We report a case of HCC with portal vein thrombosis mimicking pancreatic cancer. The diagnosis was made by endoscopic ultrasound (EUS) and the presence of tumor thrombus in the portal vein was confirmed by fine needle aspiration (FNA). …
Literature
1.
go back to reference Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterolgy 127:S35–S50CrossRef Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterolgy 127:S35–S50CrossRef
2.
go back to reference Kurtovic J, Van Der Wall H, Riordan SM (2005) FDG PET for discrimination between tumor extension and blood thrombus as a cause for portal vein thrombosis in hepatocellular carcinoma: important role in exclusion of transplant candidacy. Clin Nucl Med 30(6):408–410PubMedCrossRef Kurtovic J, Van Der Wall H, Riordan SM (2005) FDG PET for discrimination between tumor extension and blood thrombus as a cause for portal vein thrombosis in hepatocellular carcinoma: important role in exclusion of transplant candidacy. Clin Nucl Med 30(6):408–410PubMedCrossRef
3.
go back to reference Khorana AA, Fine RL (2004) Pancreatic cancer and thromboembolic disease. Lancet Oncol 5(11):655–663PubMedCrossRef Khorana AA, Fine RL (2004) Pancreatic cancer and thromboembolic disease. Lancet Oncol 5(11):655–663PubMedCrossRef
4.
go back to reference Barone D, Onetto M, Conio M, Paganuzzi M, Saccomanno S, Aste H, Pugliese V (1988) CA 19-9 assay in patients with extrahepatic cholestatic jaundice. Int J Biol Markers 3(2):95–100PubMed Barone D, Onetto M, Conio M, Paganuzzi M, Saccomanno S, Aste H, Pugliese V (1988) CA 19-9 assay in patients with extrahepatic cholestatic jaundice. Int J Biol Markers 3(2):95–100PubMed
5.
go back to reference Fabris C, Basso DA, Leandro G, Meggiato T, Elba S, Panozzo MP, Del Favero G, Fogar P, Di Mario F, Naccarato R (2001) Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis. Cancer 68(8):1795–1798CrossRef Fabris C, Basso DA, Leandro G, Meggiato T, Elba S, Panozzo MP, Del Favero G, Fogar P, Di Mario F, Naccarato R (2001) Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis. Cancer 68(8):1795–1798CrossRef
7.
go back to reference Bruno D, Bencivenga A, Menga S, Tinessa V (2004) Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 127:S108-S112 Bruno D, Bencivenga A, Menga S, Tinessa V (2004) Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 127:S108-S112
8.
go back to reference Yang L, Lin LW, Lin XY, et al. (2005) Ultrasound-guided needle aspiration biopsy in differential diagnosis of portal vein tumor thrombosis. Hepatobil Pancreat Dis Int 4(2):243–248 Yang L, Lin LW, Lin XY, et al. (2005) Ultrasound-guided needle aspiration biopsy in differential diagnosis of portal vein tumor thrombosis. Hepatobil Pancreat Dis Int 4(2):243–248
9.
go back to reference Hollerbach S, Reiser M, Topalidis T, Konig M, Schmiegel W (2003) Dignosis of hepatocellular carcinoma (HCC) in a high-risk patient by using transgastric EUS-guided fine needle biopsy (EUS-FNA). Z Gastroenterol 41:995–988PubMedCrossRef Hollerbach S, Reiser M, Topalidis T, Konig M, Schmiegel W (2003) Dignosis of hepatocellular carcinoma (HCC) in a high-risk patient by using transgastric EUS-guided fine needle biopsy (EUS-FNA). Z Gastroenterol 41:995–988PubMedCrossRef
10.
go back to reference Nguyen P, Feng JC, Chang KJ (1999) Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions. Gastrointest Endosc 50(3):357–361PubMedCrossRef Nguyen P, Feng JC, Chang KJ (1999) Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions. Gastrointest Endosc 50(3):357–361PubMedCrossRef
11.
go back to reference tenBerge J, Hoffman BJ, Hawes RH, Van Enckevort C, Giovannini M, Erickson RA, Catalano MF, Fogel R, Mallery S, Faigel DO, Ferrari AP, Waxman I, Palazzo L, Ben-Menachem T, Jowell PS, McGrath KM, Kowalski TE, Nguyen CC, Wassef WY, Yamao K, Chak A, Greenwald BD, Woodward TA, Vilmann P, Sabbagh L, Wallace MB (2002) EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc 55(7):859–862PubMedCrossRef tenBerge J, Hoffman BJ, Hawes RH, Van Enckevort C, Giovannini M, Erickson RA, Catalano MF, Fogel R, Mallery S, Faigel DO, Ferrari AP, Waxman I, Palazzo L, Ben-Menachem T, Jowell PS, McGrath KM, Kowalski TE, Nguyen CC, Wassef WY, Yamao K, Chak A, Greenwald BD, Woodward TA, Vilmann P, Sabbagh L, Wallace MB (2002) EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc 55(7):859–862PubMedCrossRef
12.
go back to reference Lai L, Brugge WR (2004) Endoscopic ultrasound is a sensitive and specific test to diagnose portal venous system thrombosis (PVST). Am J Gastroenterol 99lin(1):40–44CrossRef Lai L, Brugge WR (2004) Endoscopic ultrasound is a sensitive and specific test to diagnose portal venous system thrombosis (PVST). Am J Gastroenterol 99lin(1):40–44CrossRef
13.
go back to reference Lai R, Stephens V, Bardales R (2004) Diagnosis and staging of hepatocellular carcinoma of by EUS-FNA of a portal vein thrombus. Gastrointest Endosc 59(4):574–577 Lai R, Stephens V, Bardales R (2004) Diagnosis and staging of hepatocellular carcinoma of by EUS-FNA of a portal vein thrombus. Gastrointest Endosc 59(4):574–577
Metadata
Title
Hepatocellular Carcinoma (HCC) with Portal Vein Invasion, Masquerading as Pancreatic Mass, Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA)
Authors
Ian Storch
Carmen Gomez
Francisco Contreras
Eugene Schiff
Afonso Ribeiro
Publication date
01-03-2007
Published in
Digestive Diseases and Sciences / Issue 3/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9325-8

Other articles of this Issue 3/2007

Digestive Diseases and Sciences 3/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.